RE: Sclp AGM21 Oct 2020 21:18
Bunsie, well it is a good suggestion and my two choices would be Burble and Bermudashorts.
With the best will in the world many of us woule have good questions to ask,, bt I am sure quite a few them would not have a good chance of being answered unless very carefully worded, I have found that works well with the BOD although I haven"t e-mailed them for some time. There just seems to be so many questions to ask these days with more platforms and candidates
So many issues could well be answered by the BOD now we have the necessary funding to act, and the simple fact that Redmile have invested so heavily here suggests there are many reasons why and to which they are privy too.
With retrospect now Vulpes certainly had a Plan B, which was IMHO to keep the lights on and give them time to get an investor/s the size of Redmile on board. Perhaps too with the help of Big Pharma we have arrived at this situation, which has seen a great return for Vulpes, with no sign they will be selling out and now Redmile looking for an even bigger return, and that in itself shows us we at least come into that catagory by Redmiles external validation of Scancell alone.
I am certainly very excited by the opportunity afforded to us which again would have put Scancell under the microscope as was the case with Vulpes, and a small rise now to 16.5p would mean we have risen 300% from the days of 5.5p and funnily enough, Ruck are you reading?? another 300% puts us on 49.5p just .5p away from our 50p valuation. One of the most asked questions would probably be when can we envisage getting our trials recruiting and till first patients injected, which must have been very much on Redmiles minds, Just perhaps given the Covid situation ,that will be earlier than what some of us might have imagined.
It has been suggested by some that £45m is not a big investment from Redmile, well I don"t subscribe to that and as I felt with Vulpes, Redmile have a Plan B and C too, which IMHO will be collecting data from trials ASAP with our sights set on an admission to NASDAQ within the next 2/3 years, and I omit Avidamab and COVIDITY to stress the value attached to Immunabody and Moditope alone.
Well it sure makes for exciting times now that particular elephant in the room has been taken away, which is why afte deciding more than a few times to not invest more, do exactly the opposite with another £4k today.
So Bunsie, yes a great idea, one I am sure we will agree to adopt, and we wil just have to wait until the 9th of November to hear what news Scancell have to release before deciding what questions we should be asking. For me and my further investment I believe we will be getting news after the OO placing is concluded up until the 9th November the date of the AGM.
Good luck to all, whatever you decide, for me it wasn"t just a case of being able to afford more, but a case of could I afford not too. ATVB and GN, I think tomorrow we turn blue again.
Sign In
Follow the stocks
